Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by hydrocarbsson Sep 02, 2019 11:49am

179 Views

Post# 30088158

RE:RE:RE:Some sources for due diligence

My thinking is mostly irrelavent. Substantial from $45 million could be 10 times that. That would leave TLT only needing another 750 Million added to the Market Cap.

I cannot move the needle...

Just think, if one could put together a financial team, raise 10-15 Million US, one could have controlling ownership in a multi-billion $ company.

Bullboard Posts

@ the Bell: TSX advances to start off Christmas trading week